TERN
NASDAQ · Pharmaceuticals
Terns Pharmaceuticals Inc
$52.86
+2.86 (+5.72%)
Performance
1D
—
1W
—
1M
—
3M
+27.31%
6M
+578.56%
1Y
+1,605.16%
YTD
+31.79%
Open$52.63
Previous Close$50.00
Day High$52.98
Day Low$52.59
52W High$48.26
52W Low$1.87
Volume—
Avg Volume1.60M
Market Cap4.19B
P/E Ratio—
EPS$-1.03
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$38.73
Above
SMA 200
$16.20
Above
RSI (14)
69
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-29.7% upside
Current
$52.86
$52.86
Target
$37.17
$37.17
$32.00
$37.17 avg
$56.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 649.21M | 641.61M | 607.21M |
| Net Income | 208.45M | 199.92M | 172.59M |
| Profit Margin | 32.1% | 31.2% | 28.4% |
| EBITDA | 253.94M | 217.05M | 208.00M |
| Free Cash Flow | 152.21M | 227.98M | 177.76M |
| Rev Growth | -4.4% | +22.1% | +20.7% |
| Debt/Equity | 0.17 | 0.24 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |